Stay updated on Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter revision note updated from Revision: v3.3.1 to Revision: v3.3.2. No changes to the study details or other user-facing content.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed. The update appears limited to metadata and does not change the study details, eligibility criteria, or locations shown on the page.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding/operating status notice banner shown on the page has been removed.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show only minor UI/layout adjustments; core study details such as title, conditions, eligibility, enrollment, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check72 days agoChange DetectedUpdate includes operating-status notice and a resource removal, plus a version bump to v3.2.0; core content and a specific topic (Gastrointestinal stromal tumor) were affected.SummaryDifference6%

- Check79 days agoChange DetectedUpgrade to v3.1.0 (from v3.0.2); a new revision tag is added and an identifier (008613601310849) is introduced, indicating a new release without altering core content or critical data.SummaryDifference0.1%

Stay in the know with updates to Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.